# Inocras

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inocras-2

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.inocras.com/
- Total disclosed funding: $65M
- Latest round: Series B (Aug 3, 2026)
- Investors on record: 18

## About

Based in California, US, and founded in 2020 by co-founders Young Seok Ju and Jeong Seok Lee, Jehee Suh CEO, Inocras Inc. FKA Genome Insight Inc. is a technology-based company providing a comprehensive view of a patient's entire genetic profile through WGS analysis and interpretation. In August 2026, Inocras Inc. raised USD 31 million in series B funding from Nongshim Capital, Aimed Bio Inc., IMM Investment, Korea Investment & Securities, LoftyRock Investment, DT& Investment, Woori Investment Bank, Shinhan Securities,DSC Investment, Dunamu & Partners, InterVest.  The deal was part of larger USD 58.5 million in series B funding.
Genome Insight Inc. provides holistic information on intractable cancer and rare diseases customized diagnosis, targeted treatment, and new drug targets. The company develops a medical platform used in upgrading and scaling up to full genome analysis capabilities. The company makes whole-genome accessible and affordable; it extracts WGS insights for patients, clinicians, and industries. The company focuses on four core areas first on genomics-driven precision oncology, second on total therapeutics for a rare and orphan disease, thirdly on a tailored model for infectious and inflammatory diseases, and fourthly on techniques for high-end genomics research. Additionally, the firm constructs a population-scale medical whole-genome database to build the essential infrastructure for precision healthcare. The company will use the funding to expand its whole-genome sequencing and proprietary bioinformatics platform in the United States and build its U.S. commercial and operational infrastructure.

## Funding rounds

- Series B, Aug 3, 2026, $31M — Korea Investment & Securities, InterVest, Shinhan Securities, DSC Investment, IMM Investment, DT&Investment, Dunamu & Partners, Nongshim Capital, Woori Investment Bank, Loftyrock Investment, Aimed Bio Inc.
- Series B, May 31, 2023, $4.5M — Samsung Venture Investment, Asan Foundation, Ignite Innovation
- Series B, Apr 29, 2022, $23M — InterVest, DSC Investment, Paratus Investment, Dunamu & Partners, Schmidt, Signite, VNTG CORP
- Series A, Nov 27, 2020, $6M — DSC Investment, Paratus Investment, Schmidt
- Seed, Feb 27, 2020, $0.3M — DSC Investment, Schmidt

## Investors

- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Seed, Series A, Series B
- Schmidt (https://capitalatlas.ai/funds/schmidt) — Seed, Series A, Series B
- Paratus Investment (https://capitalatlas.ai/funds/paratus-investment) — Series A, Series B
- InterVest (https://capitalatlas.ai/funds/intervest) — Series B
- Dunamu & Partners (https://capitalatlas.ai/funds/dunamu-partners) — Series B
- Signite (https://capitalatlas.ai/funds/signite) — Series B
- VNTG CORP — Series B
- Samsung Venture Investment (https://capitalatlas.ai/funds/samsung-venture-investment) — Series B
- Asan Foundation — Series B
- Ignite Innovation (https://capitalatlas.ai/funds/ignite-innovation) — Series B
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- Shinhan Securities (https://capitalatlas.ai/funds/shinhan-securities) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B
- DT&Investment (https://capitalatlas.ai/funds/dt-investment) — Series B
- Nongshim Capital (https://capitalatlas.ai/funds/nongshim-capital) — Series B
- Woori Investment Bank (https://capitalatlas.ai/funds/woori-investment-bank) — Series B
- Loftyrock Investment (https://capitalatlas.ai/funds/loftyrock-investment) — Series B
- Aimed Bio Inc. — Series B